Skip to main content
RANI logo

RANI · Rani Therapeutics Holdings, Inc. · Webcasts, Transcripts & Audio

Track RANI — free
$0.58 +0.02 (+4.03%) Play latest call Q4 2025 earnings call transcript
Market Cap
$80.74M
Shares
139.40M
Volume · Nov 4 169.69K Avg daily vol (3M) 593.77K

Rani Therapeutics Holdings, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Rani Therapeutics Holdings, Inc. (RANI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-10-20
Rani Therapeutics Holdings, Inc. (RANI) October 20, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-12
Rani Therapeutics Holdings, Inc. (RANI) August 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-26
Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript
Confident tone RaniPill platform validation RT114 (oral bispecific GLP-1/GLP-2) clinical progress Chugai partnership
Revenue
$1.46M*
▲ 42.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q4
2025-03-31
Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call
Revenue
$1.03M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q4
2024-03-20
Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript
Confident tone RT-111 Phase 1 ustekinumab biosimilar results Celltrion partnership and biosimilar supply Obesity market opportunity and pipeline
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q4
2023-03-22
Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q4
2022-03-29
Rani Therapeutics Holdings, Inc. (RANI) Q4 2021 Earnings Call Transcript
Revenue
$0*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–7 of 7 webcasts
Key facts CIK 1856725 CUSIP 753018100 13F (30d) 12 filings 12 filers Visit website Investor relations